tirzepatide vs semaglutide pros cons Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity semaglutide vs tirzepatide pros cons

ABSTRACT Objective SURMOUNTMAINTAIN aims to evaluate the efficacy and safety of reducing the tirzepatide dose and/or continuing the maximum tolerated dose (MTD) versus placebo in maintaining body weight (BW) reduction achieved with tirzepatide MTD

Key points: Despite only being released into the Australian market a few months ago, Mounjaro is in short supply It has been approved by the TGA as a diabetes treatment but is being prescribed "off-label" for weight loss The shortage has surprised doctors and patients, who are now looking for alternatives On Wednesday, pharmaceutical company Eli Lilly issued an alert and warned that most doses of the drug Mounjaro were currently unavailable due to "larger-than-expected demand"

Also, the longer you take Zepbound , the more you spend overall

Safety First: When to Consult a Provider While the math behind 25 units might seem simple, medication safety is complex

Symptoms include dizziness, sweating, confusion, and extreme hunger Severe side effects: Nausea or vomiting that prevents eating, severe abdominal pain, or other side effects affecting nutrition Binge eating episodes: Uncontrollable eating despite the medication Your healthcare provider may need to adjust your dose, check for other medical conditions, or provide additional support strategies